All Articles

Past, present, and future of microbiome-based therapies

A host-microbial metabolite interaction gut-on-a-chip model of the adult human intestine demonstrates beneficial effects upon inulin treatment of gut microbiome

The biofunction of Akkermansia muciniphila in intestinal-related diseases

Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis

Early-life gut microbiome development and its potential long-term impact on health outcomes

Phage therapy as a revitalized weapon for treating clinical diseases

Compendium of Bifidobacterium-based probiotics: characteristics and therapeutic impact on human diseases

Pangenomic analysis identifies correlations between Akkermansia species and subspecies and human health outcomes

Screening competition and cross-feeding interactions during utilization of human milk oligosaccharides by gut microbes

Synergistic vs. complementary synbiotics: the complexity of discriminating synbiotic concepts using a Lactiplantibacillus plantarum exemplary study

Bifidobacterium longum subsp. infantis regulates Th1/Th2 balance through the JAK-STAT pathway in growing mice

Recent advances in gut microbiota-mediated regulation of fat deposition and metabolic disorders

Assessing fecal metaproteomics workflow and small protein recovery using DDA and DIA PASEF mass spectrometry

Microbiota-gut-liver-brain axis and hepatic encephalopathy

Lactobacillus johnsonii CCFM1376 improves hypercholesterolemia in mice by regulating the composition of bile acids

Host-dependent alteration of the gut microbiota: the role of luminal microRNAs

Comparative genome analysis of microbial strains marketed for probiotic interventions: an extension of the Integrated Probiotic Database

Supplementation with a cranberry extract favors the establishment of butyrogenic guilds in the human fermentation SHIME system